BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33009373)

  • 1. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.
    Chen T; Dai X; Dai J; Ding C; Zhang Z; Lin Z; Hu J; Lu M; Wang Z; Qi Y; Zhang L; Pan R; Zhao Z; Lu L; Liao W; Lu X
    Cell Death Dis; 2020 Oct; 11(10):822. PubMed ID: 33009373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
    Zheng Y; Zhu M; Li M
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumor 1 gene modulates Fas-related death signals and anti-apoptotic functions in hepatocellular carcinoma.
    Uesugi K; Hiasa Y; Tokumoto Y; Mashiba T; Koizumi Y; Hirooka M; Abe M; Matsuura B; Onji M
    J Gastroenterol; 2013 Sep; 48(9):1069-80. PubMed ID: 23142971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
    Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
    Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.
    Zhu H; Berkova Z; Mathur R; Sehgal L; Khashab T; Tao RH; Ao X; Feng L; Sabichi AL; Blechacz B; Rashid A; Samaniego F
    Mol Cancer Res; 2015 May; 13(5):809-18. PubMed ID: 25678597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
    Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
    J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma.
    Shen S; Feng H; Liu L; Su W; Yu L; Wu J
    BMB Rep; 2020 Aug; 53(8):431-436. PubMed ID: 32438969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
    Tahtouh R; Azzi AS; Alaaeddine N; Chamat S; Bouharoun-Tayoun H; Wardi L; Raad I; Sarkis R; Antoun NA; Hilal G
    PLoS One; 2015; 10(3):e0119512. PubMed ID: 25822740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rs217727 polymorphism in H19 promotes cell apoptosis by regulating the expressions of H19 and the activation of its downstream signaling pathway.
    Ge L; Wang Q; Hu S; Yang X
    J Cell Physiol; 2019 May; 234(5):7279-7291. PubMed ID: 30362559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
    Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
    Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
    Saito S; Ojima H; Ichikawa H; Hirohashi S; Kondo T
    Cancer Sci; 2008 Dec; 99(12):2402-9. PubMed ID: 19038010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AUF1 promotes hepatocellular carcinoma progression and chemo-resistance by post-transcriptionally upregulating alpha-fetoprotein expression.
    Zhang J; Zhang T; Guan G; Wen J; Chen CC; Liu J; Duan Y; Liu Y; Chen X
    Pathol Res Pract; 2023 May; 245():154441. PubMed ID: 37060820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway.
    Zhang C; Zhang J; Wang J; Yan Y; Zhang C
    J Cell Mol Med; 2020 Dec; 24(23):13804-13812. PubMed ID: 33090723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm.
    Zhang C; Chen X; Liu H; Li H; Jiang W; Hou W; McNutt MA; Lu F; Li G
    Int J Cancer; 2015 Oct; 137(8):1818-29. PubMed ID: 25846475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
    Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
    Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.
    Li R; Okada H; Yamashita T; Nio K; Chen H; Li Y; Shimakami T; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.